News search
About the CNIC 6 Feb 2025 The accreditation confirms the reliability of the units’ technical output and facilitates external collaborations, factors crucial to sustaining the CNIC’s leadership in cardiovascular research |
Research 4 Feb 2025 The study, published in JACC: CardioOncology, shows that administration of the SGLT2 inhibitor empagliflozin to pigs receiving anthracyclines preserves mitochondrial function, improves myocardial energetics, and prevents degenerative changes in heart structure |
Research 22 Jan 2025 Scientists at the CNIC have discovered how gut bacteria that cross a weakened intestinal barrier induce changes in bone marrow that strengthen the immune response |
About the CNIC 20 Jan 2025 An international study led by Spanish research teams has identified how genetic factors can influence the severity of disease caused by SARS-CoV-2 |
About the CNIC 15 Jan 2025 The study describes an innovative probe for the noninvasive detection of macrophages using PET technology |
About the CNIC 13 Jan 2025 This work reveals a new mechanism by which brown fat is converted into heat, and which protects from pathologies associated with obesity. |
Research 12 Dec 2024 iFlpMosaics is a new technology presented in Nature Methods that allows the modification and study of gene function in mouse models, advancing research on diseases caused by somatic mutations, such as cancer and vascular malformations. |
About the CNIC 12 Dec 2024 The new project, ‘The Placenta in Maternal and Fetal Cardiovascular Health and Disease’, aims to understand how the placenta influences cardiovascular health in mothers and their children, promising improvements in the prevention and treatment of related diseases |
About the CNIC 5 Dec 2024 The International Atherosclerosis Society recognizes the contributions to the understanding and treatment of atherosclerosis by the director of the National Center for Cardiovascular Research (CNIC) and president of the Mount Sinai Fuster Heart |
About the CNIC 25 Nov 2024 Carola García de Vinuesa is a senior group leader at the Francis Crick Institute in London and the John Curtin School of Medical Research in Canberra. |
- 1 of 45
- next ›